Juli Miller | Director of IR |
James Noble | CEO & Director |
Rafael Amado | Chief Medical Officer |
Adrian Rawcliffe | Chief Financial Officer |
Jonathan Chang | Leerink Partners |
Marc Frahm | Cowen and Company |
Robyn Karnauskas | Citi |
Peter Lawson | SunTrust Robinson Humphrey |
Michael Schmidt | Gugenheim |
Ren Benjamin | Raymond James |
Jim Birchenough | Wells Fargo Securities |
Ying Huang | Bank of America Merrill Lynch |
Good day, ladies and gentlemen, and welcome to the Third Quarter 2018 Adaptimmune Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I now like to introduce your host for today’s conference, Ms. Juli Miller. Ma'am, you may begin.